

Health Library
October 10, 2025
Question on this topic? Get an instant answer from August.
I-Aclidinium iyimithi kadokotela esiza abantu abanesifo sokuvuvukala kwamaphaphu okungamahlalakhona (i-COPD) baphefumule kalula. Isebenza ngokukhulula imisipha ezungeze izindlela zakho zomoya, okwenza kube nzima ukungena nokuphuma komoya emaphashini akho.
Le mithi iza njenge-inhaler yomuthi owomile oyisebenzisa kabili ngosuku. Cabanga ngayo njengokwelashwa kwansuku zonke kunokuba yi-inhaler yokuhlenga ngezinkinga zokuphefumula ezingazelelwe.
I-Aclidinium ingeyeqembu lemithi ebizwa ngokuthi ama-antagonists e-muscarinic esebenza isikhathi eside noma ama-LAMA. Yenzelwe ngokuqondile ukusiza ukuphatha izimpawu ze-COPD ngokugcina izindlela zakho zomoya zivulekile isikhathi eside.
Umuthi usebenza ngendlela ehlukile kuma-inhaler okukhulula ngokushesha. Ngenkathi ama-inhaler okuhlenga enikeza ukukhululeka okusheshayo kodwa kwesikhashana, i-aclidinium inikeza izinzuzo eziqhubekayo ezisiza ukuvimbela ubunzima bokuphefumula usuku lonke.
Udkt wakho ngokuvamile uzonquma lo muthi uma udinga ukuphathwa njalo, kwansuku zonke kwezimpawu zakho ze-COPD. Akuhloselwe ukuthi ithathe indawo ye-inhaler yakho yokuhlenga kodwa isebenza eceleni kwayo njengengxenye yohlelo lwakho lokwelashwa olujwayelekile.
I-Aclidinium isetshenziselwa ikakhulukazi ukwelapha isifo sokuvuvukala kwamaphaphu okungamahlalakhona (i-COPD), okuhlanganisa izimo ezinjenge-chronic bronchitis kanye ne-emphysema. Isiza ukunciphisa imvamisa nobukhulu bobunzima bokuphefumula obuhambisana nalezi zimo.
Umuthi ulusizo ikakhulukazi kubantu ababa nezimpawu zansuku zonke njengokuphefumula kanzima, ukuhoshoza, noma ukuqina kwesifuba. Isebenza njengokwelashwa kokulondoloza, okusho ukuthi uyayithatha njalo ukuvimbela izimpawu kunokuba ulinde ukuthi zenzeke.
Udkt wakho angase anqume i-aclidinium uma eminye imithi ye-COPD ingazange inikeze ukukhululeka okwanele, noma njengengxenye yendlela yokwelapha ehlanganisiwe. Ilusizo ikakhulukazi kubantu abadinga ukusekelwa kwezindlela zomoya okuqhubekayo usuku lonke.
I-Aclidinium isebenza ngokuvimba izamukeli ezithile emisipheni yakho yomoya ebizwa ngokuthi izamukeli ze-muscarinic. Uma lezi zamukeli zivinjwe, imisipha ezungeze imigudu yakho yomoya iyakhululeka futhi ihlale ivulekile isikhathi eside.
Lokhu kuthathwa njengomuthi oqinile ngokulinganisela esigabeni sokwelashwa kwe-COPD. Inikeza ukukhululeka okuqhubekayo, okuhlala isikhathi eside okuvame ukuhlala cishe amahora angu-12 ngomthamo ngamunye, yingakho uwuthatha kabili ngosuku.
Umuthi uqala ukusebenza kungakapheli amahora ambalwa ngomthamo wakho wokuqala, kodwa cishe uzoqaphela ukuthuthuka okukhulu ngemuva kokuwusebenzisa njalo amasonto ambalwa. Imigudu yakho yomoya kancane kancane iba ngaphansi kokusabela futhi izinzile ngokuhamba kwesikhathi.
Thatha i-aclidinium ngendlela eqondile udokotela wakho ayalela ngayo, ngokuvamile kabili ngosuku ngamunye ngamunye emva kwamahora angu-12. Ishejuli ejwayelekile ukuthatha kanye ekuseni kanye kanye kusihlwa.
Awudingi ukuthatha lo muthi nokudla, futhi ungawuthatha esiswini esingenalutho uma lokho kulula. Kodwa-ke, hlambulula umlomo wakho ngamanzi ngemuva komthamo ngamunye ukuvimbela ukucasuka komlomo noma izifo.
Nansi indlela yokusebenzisa i-aclidinium inhaler yakho ngendlela efanele:
Njalo sebenzisa i-inhaler ekamelweni lokushisa, futhi uyigcine yomile. Uma unenkinga ngobuchwepheshe, cela udokotela wakho noma usokhemisi ukuthi akubuke uyisebenzisa futhi akunike isiqondiso.
Abantu abaningi abane-COPD badinga ukuthatha i-aclidinium njengomuthi wokugcina isikhathi eside. Njengoba i-COPD iyisimo esingamahlalakhona, ukuyeka umuthi ngokuvamile kusho ukuthi izimpawu zakho zizobuya.
Udkt wakho ngokuvamile uzofuna ukuthi usebenzise i-aclidinium okungenani amasonto angu-4-6 ukuze uhlole ngokugcwele ukuthi isebenza kahle kangakanani kuwe. Ngesikhathi esinjalo, bazobheka ukusebenza kokuphefumula kwakho kanye nokulawulwa kwezimpawu zakho.
Abanye abantu bangase badinge ukuthatha lo muthi iminyaka eminingi, kanti abanye bangase bashintshele kwezinye izindlela zokwelapha ngokusekelwe ekutheni isimo sabo siqhubeka kanjani. Ungalokothi uyeke ukuthatha i-aclidinium ngokuzumayo ngaphandle kokukhuluma nodokotela wakho kuqala, ngoba lokhu kungaholela ekubhebhethekeni kwezimpawu.
Njengayo yonke imithi, i-aclidinium ingabangela imiphumela emibi, nakuba abantu abaningi bengabi nazinkinga eziningi. Imiphumela eminingi emibi imnene futhi ivame ukuthuthuka njengoba umzimba wakho ujwayela umuthi.
Imiphumela emibi evame kakhulu ongase uyithole ihlanganisa:
Lezi zimpawu ngokuvamile zisesikhashana futhi azikudingi ukuthi uyeke umuthi. Kodwa-ke, uma ziba yizithiyo noma ziqhubeka, yazisa udokotela wakho.
Imiphumela emibi engavamile kodwa ebucayi ingahlanganisa ubunzima bokuchama, ubuhlungu emehlweni noma izinguquko embonweni, noma izimpawu zokungezwani komzimba nezinto ezithile njengokuqubuka noma ukuvuvukala. Uma uhlangabezana nanoma yiziphi zalezi zimpawu, xhumana nodokotela wakho ngokushesha.
Ngokuvamile, abanye abantu bangase babe nokungezwani komzimba okukhulu, ukushaya kwenhliziyo okungajwayelekile, noma ubunzima obukhulu bokuphefumula obuhlukile ezimpawini zabo ezivamile ze-COPD. Lezi zimo zidinga ukunakekelwa kwezempilo ngokushesha.
I-Aclidinium ayifanele wonke umuntu, futhi udokotela wakho uzocabangela izinto eziningana ngaphambi kokuyinika. Abantu abanezimo ezithile zezokwelapha bangase badinge ukugwema lo muthi noma bawusebenzise ngokuqapha okwengeziwe.
Akufanele uthathe i-aclidinium uma unenkinga yokungezwani nayo noma nganoma yiziphi izithako zayo. Udokotela wakho uzophinda aqaphele ngokuyinika uma unezimo ezithile zamehlo njenge-narrow-angle glaucoma.
Abantu abanezinkinga ezinzima zezinso, i-prostate enwetshiwe, noma ukuvinjelwa kwesinye bangase badinge imithi ehlukile noma badinge ukuqapha ngokucophelela ngenkathi besebenzisa i-aclidinium. Ngaphezu kwalokho, uma ukhulelwe noma uncelisa, xoxa ngezingozi nezinzuzo nodokotela wakho.
Lo muthi awuvunyelwe ukwelapha isifuba somoya noma ukusetshenziswa ezinganeni ezingaphansi kweminyaka engu-18 ubudala. Futhi akuhloselwe ukuba kube umuthi wokusiza ezimweni eziphuthumayo zokuphefumula.
I-Aclidinium itholakala ngaphansi kwegama lomkhiqizo elithi Tudorza Pressair e-United States. Le yindlela evame kakhulu yokunikezwa yomuthi.
Inguqulo yegama lomkhiqizo iza njenge-dry powder inhaler equkethe imithamo elinganiselwe yomuthi. I-inhaler ngayinye ngokuvamile iqukethe imithamo engama-60, ethatha cishe inyanga eyodwa uma isetshenziswa kabili ngosuku njengoba kunqunywe.
Izinhlobo ze-generic ze-aclidinium zingase zitholakale esikhathini esizayo, kodwa njengamanje, i-Tudorza Pressair iyindlela eyinhloko etholakala ezigulini emazweni amaningi.
Eminye imithi eminingana isebenza ngendlela efanayo ne-aclidinium yokuphatha i-COPD. Lezi ezinye izindlela zingezesigaba esifanayo somuthi (ama-LAMA) noma zinikeze izinzuzo ezifanayo ngemishini ehlukene.
Ezinye izitha ze-muscarinic ezisebenza isikhathi eside zihlanganisa i-tiotropium (Spiriva), i-umeclidinium (Incruse Ellipta), kanye ne-glycopyrrolate (Lonhala Magnair). Udokotela wakho angase acabangele lokhu uma i-aclidinium ingasebenzi kahle kuwe noma ibangela imiphumela emibi.
Abanye abantu bayazuza emithini ehlanganisiwe ehlanganisa i-aclidinium neminye imithi ye-COPD. Ngokwesibonelo, i-Duaklir Pressair ihlanganisa i-aclidinium ne-formoterol, i-beta-agonist esebenza isikhathi eside.
Udkt wakho uzokhetha elinye elingcono kakhulu ngokusekelwe ezimpawini zakho ezithile, eminye imithi oyithathayo, nokuthi usabela kahle kangakanani ekwelashweni okuhlukene. Umgomo ukuthola inketho esebenza kahle kakhulu enezinto ezimbalwa ezingezinhle esimweni sakho.
Kokubili i-aclidinium ne-tiotropium ziyimithi ephumelelayo ye-COPD, kodwa zisebenza ngendlela ehlukile kancane futhi zingase zilingane nabantu abahlukene kangcono. Akukho noyedwa “ongcono” kunomunye.
I-Aclidinium ithathwa kabili ngosuku, kuyilapho i-tiotropium ithathwa kanye ngosuku. Abanye abantu bakhetha ukuthatha kabili ngosuku ngoba kunikeza ukulawulwa kwezimpawu okuqhubekayo usuku lonke.
Ucwaningo luphakamisa ukuthi yomibili imithi isebenza kahle ngokufanayo ekuthuthukiseni ukusebenza kwamaphaphu nokunciphisa izimpawu ze-COPD. Kodwa-ke, i-aclidinium ingase ibe nengozi ephansi yokugcinwa komchamo, okungase kubaluleke kubantu abadala noma abantu abanezinkinga ze-prostate.
Udkt wakho uzocabangela izinto ezinjengomsebenzi wakho wansuku zonke, ezinye izimo zempilo, nokuthi usabela kanjani emithini ngayinye lapho enquma ukuthi iyiphi engcono kuwe mathupha.
I-Aclidinium ngokuvamile ithathwa njengephephile kubantu abanesifo senhliziyo, kodwa udkt wakho uzokuqapha ngokucophelela uma unezimo ze-cardiovascular. Umuthi unengozi ephansi yezinto ezingezinhle ezihlobene nenhliziyo uma kuqhathaniswa neminye imithi ye-COPD.
Kodwa-ke, abantu abanokushaya kwenhliziyo okungajwayelekile noma ukuhlaselwa yinhliziyo kwakamuva bangase badinge ukuqashwa okwengeziwe. Hlala wazisa udkt wakho nganoma yiziphi izimo zenhliziyo ngaphambi kokuqala i-aclidinium, futhi ubike noma yikuphi ukucasuka esifubeni, ukushaya kwenhliziyo okusheshayo, noma izimpawu ezingavamile.
Uma ngengozi uthatha umthamo owengeziwe we-aclidinium, ungesabi. Umthamo owengeziwe ngezikhathi ezithile akunakwenzeka ukuthi ube yingozi enkulu, kodwa ungase uhlangabezane nemiphumela eminingi efana nekhanda elibuhlungu, umlomo owomile, noma isiyezi.
Xhumana nodokotela wakho noma usokhemisi ukuze uthole iseluleko, ikakhulukazi uma uzizwa ungaphilile noma uhlangabezana nezimpawu ezingavamile. Ungazami 'ukuqaqa' umthamo wakho olandelayo ukuze ulungise lowo owengeziwe - vele ubuyele esimisweni sakho esijwayelekile.
Uma uthathe okuningi kakhulu kunokunqunyiwe noma uhlangabezana nezimpawu ezinzima, funa ukunakekelwa kwezempilo ngokushesha. Gcina umkhondo wokuthi uthathe nini futhi kangakanani ukuze usize abahlinzeki bezempilo ukuthi bahlole isimo.
Uma uqaqa umthamo we-aclidinium, wuthatha ngokushesha lapho ukhumbula, ngaphandle uma sekuyisikhathi somthamo wakho olandelayo. Kulokho, qeqe umthamo oqashiwe bese uqhubeka nesimiso sakho esijwayelekile.
Ungalokothi uthathe imithamo emibili ngesikhathi esisodwa ukuze ulungise umthamo oqashiwe, ngoba lokhu kwandisa ingozi yakho yemiphumela emibi. Uma uvame ukukhohlwa imithamo, cabanga ukusetha izikhumbuzi zocingo noma usebenzise umhleli wamaphilisi.
Ukuqaqa imithamo ngezikhathi ezithile ngeke kubangele ingozi ngokushesha, kodwa ukusetshenziswa okuqhubekayo kubalulekile ukuze umuthi usebenze ngempumelelo. Uma uqaqa imithamo njalo, khuluma nodokotela wakho ngamasu okuthuthukisa ukunamathela.
Kufanele uyeke kuphela ukuthatha i-aclidinium ngaphansi kwesiqondiso sikadokotela wakho. Njengoba i-COPD iyisimo esingamahlalakhona, ukuyeka imithi yokugcinwa ngokuvamile kuholela ekubhebhethekeni kwezimpawu futhi okungenzeka kube nezinkinga zokuphefumula ezinzima.
Udokotela wakho angase acabange ukuyeka noma ukushintsha imithi yakho uma uhlangabezana nemiphumela emibi ebalulekile, uma isimo sakho sithuthuke kakhulu, noma uma ushintshela endleleni yokwelapha ehlukile.
Ngaphambi kokwenza noma yiziphi izinguquko, udokotela wakho cishe uzofuna ukuhlola ukusebenza kwamaphaphu akho njengamanje kanye nesimo sempilo yakho esiphelele. Bangase futhi bafune ukukuqapha eduze ngesikhathi sokushintsha ukuze baqinisekise ukuthi izimpawu zakho zihlala zilawulwa kahle.
Yebo, ungaqhubeka usebenzisa i-inhaler yakho yokuhlenga (njenge-albuterol) kanye ne-aclidinium uma kudingeka. Le mithi isebenza ngezindlela ezahlukene futhi isebenzela izinjongo ezahlukene ekuphathweni kwakho kwe-COPD.
I-Aclidinium inikeza ukulawulwa kwezimpawu zesikhathi eside, kuyilapho ama-inhaler okuhlenga enikeza ukukhululeka okusheshayo ngesikhathi sezimo eziphuthumayo zokuphefumula noma ukuqubuka kwezimpawu kungazelelwe. Cabanga nge-aclidinium njengokwelashwa kwakho kwansuku zonke kanye ne-inhaler yakho yokuhlenga njengokusekelwa kwakho okuphuthumayo.
Njalo thwala i-inhaler yakho yokuhlenga nawe, ngisho nalapho uthatha i-aclidinium njalo. Uma uzithola udinga i-inhaler yakho yokuhlenga kaningi kunokujwayelekile, xhumana nodokotela wakho ngoba lokhu kungase kubonise ukuthi ukuphathwa kwakho kwe-COPD kudinga ukulungiswa.
6Mpeople
Get clear medical guidance
on symptoms, medications, and lab reports.